Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GP-Act III Acquisition (GPAT) Total Liabilities (2023 - 2025)

GP-Act III Acquisition (GPAT) has disclosed Total Liabilities for 3 consecutive years, with $14.7 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities changed 0.02% to $14.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.7 million through Dec 2025, changed 0.02% year-over-year, with the annual reading at $14.7 million for FY2025, 0.02% changed from the prior year.
  • Total Liabilities for Q4 2025 was $14.7 million at GP-Act III Acquisition, roughly flat from $14.7 million in the prior quarter.
  • The five-year high for Total Liabilities was $14.8 million in Q1 2025, with the low at $84603.0 in Q1 2023.
  • Average Total Liabilities over 3 years is $8.8 million, with a median of $14.6 million recorded in 2024.
  • The sharpest move saw Total Liabilities soared 17040.94% in 2024, then rose 0.02% in 2025.
  • GP-Act III Acquisition's Total Liabilities stood at $628182.0 in 2023, then skyrocketed by 2235.17% to $14.7 million in 2024, then grew by 0.02% to $14.7 million in 2025.
  • Per Business Quant, the three most recent readings for GPAT's Total Liabilities are $14.7 million (Q4 2025), $14.7 million (Q3 2025), and $14.7 million (Q2 2025).